Nackenheim, Germany

Stefan Woll

USPTO Granted Patents = 15 

Average Co-Inventor Count = 6.7

ph-index = 5

Forward Citations = 61(Granted Patents)


Company Filing History:


Years Active: 2016-2024

Loading Chart...
15 patents (USPTO):Explore Patents

Title: **The Innovative Contributions of Stefan Woll**

Introduction

Stefan Woll is an accomplished inventor based in Nackenheim, Germany. With a remarkable portfolio of 15 patents, he has made significant contributions to the field of cancer diagnostics and therapeutics.

Latest Patents

Stefan's latest innovations include two notable patents. The first pertains to antibodies against claudin 18.2, specific to an epitope located within the C-terminal portion of CLDN18.2. These antibodies hold promise for diagnosing cancer and determining the expression of CLDN18.2 in cancer cells. The second patent involves antibodies designed for the treatment of various cancers expressing claudin 6. This invention addresses the need for therapeutics aimed at cancers such as ovarian, lung, gastric, breast, hepatic, pancreatic, skin, malignant melanoma, head and neck, sarcoma, bile duct, urinary bladder, kidney, colon, placental choriocarcinoma, cervical, testicular, and uterine cancer.

Career Highlights

Throughout his career, Stefan has contributed his expertise to prominent organizations, including Ganymed Pharmaceuticals AG and Johannes Gutenberg University Mainz. His work in these institutions has facilitated advancements in cancer-related research and therapeutic development.

Collaborations

Stefan has collaborated with other notable figures in the field, including Ugur Sahin and Ozlem Tureci. Together, they have pushed the boundaries of innovation in cancer treatment and diagnostics, fostering a collaborative environment centered on improving patient outcomes.

Conclusion

Stefan Woll's inventive spirit and dedication to advancing cancer research underscore his significance in the scientific community. With a strong portfolio of patents and impactful collaborations, he continues to pave the way for innovative solutions in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…